Bruker (BRKR) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.41% |
| Dec 31, 2025 | -4.73% |
| Sep 30, 2025 | 3.50% |
| Jun 30, 2025 | 0.97% |
| Mar 31, 2025 | -3.14% |
| Dec 31, 2024 | 5.41% |
| Sep 30, 2024 | 15.01% |
| Jun 30, 2024 | 6.45% |
| Mar 31, 2024 | 15.09% |
| Dec 31, 2023 | 9.18% |
| Sep 30, 2023 | 18.73% |
| Jun 30, 2023 | 21.16% |
| Mar 31, 2023 | 24.08% |
| Dec 31, 2022 | 22.78% |
| Sep 30, 2022 | 41.42% |
| Jun 30, 2022 | 13.27% |
| Mar 31, 2022 | 10.56% |
| Dec 31, 2021 | 20.67% |
| Sep 30, 2021 | 13.12% |
| Jun 30, 2021 | 19.69% |
| Mar 31, 2021 | 25.29% |
| Dec 31, 2020 | 20.36% |
| Sep 30, 2020 | 13.36% |
| Jun 30, 2020 | 21.40% |
| Mar 31, 2020 | 39.86% |
| Dec 31, 2019 | 31.76% |
| Sep 30, 2019 | 10.35% |
| Jun 30, 2019 | 18.82% |
| Mar 31, 2019 | 2.87% |
| Dec 31, 2018 | 17.67% |
| Sep 30, 2018 | 2.25% |
| Jun 30, 2018 | -11.42% |
| Mar 31, 2018 | -10.25% |
| Dec 31, 2017 | -11.62% |
| Sep 30, 2017 | -12.07% |
| Jun 30, 2017 | -12.58% |
| Mar 31, 2017 | -0.17% |
| Dec 31, 2016 | -9.71% |
| Sep 30, 2016 | -2.52% |
| Jun 30, 2016 | -16.89% |
| Mar 31, 2016 | -4.17% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | -0.83% |
| Jun 30, 2015 | 7.76% |
| Mar 31, 2015 | 1.09% |